New heart drug targets sticky proteins in rare disease

This study is for people with a heart condition called ATTR-CM, where abnormal protein builds up in the heart and makes it stiff. Researchers are testing a new medicine called coramitug, which is designed to bind to that protein and help remove it. The study uses special PET/CT scans to see how the drug travels in the body and whether it can clear the protein deposits. About 14 people aged 60 and older will take part to check safety and how well the drug works.